News Investor seeks sale of Novavax after poor COVID jab sales Investor Shah Capital has called on Novavax's board to put the company up for sale, citing a "litany of missteps" at the vaccine developer.
News COVID-19 vaccine support reined back by ACIP The CDC's vaccine committee reduced some support for COVID-19 vaccines, but did not go as far as some might have feared in limiting access.
News US anti-vaccine rhetoric trumpeted in UK, thanks to Reform Experts have pushed back against anti-vaccine comments made by an advisor to the Trump administration at the Reform UK conference.
News FDA ends emergency COVID authorisations, issues narrow appro... RFK has declared the end of the COVID-19 emergency as the FDA issued approvals for the 2025 COVID shots in elderly and compromised patients only.
News Lilly's appeal unlocks EU approval of Alzheimer's drug Eli Lilly's appeal of a decision by the EMA's human medicines committee not to approve its Alzheimer's disease therapy Kisunla has paid off.
News EU President fends off no-confidence vote over Pfizer texts EU President Ursula von der Leyen has survived a no-confidence vote over text messages she sent to Pfizer's CEO about COVID-19 vaccine procurement.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.